Effect of zoledronic acid therapy on postmenopausal osteoporosis between the Uighur and Han population in Xinjiang: An open-label, long-term safety and efficacy study

MLA

C. Xiang, et al. “Effect of Zoledronic Acid Therapy on Postmenopausal Osteoporosis between the Uighur and Han Population in Xinjiang: An Open-Label, Long-Term Safety and Efficacy Study.” Journal of Clinical Pharmacy and Therapeutics, vol. 43, Nov. 2017, pp. 336–41. EBSCOhost, https://doi.org/10.1111/jcpt.12647.

APA

C. Xiang, Hong Yuan, Xu Wanlong, X. Xiao, Hong Wang, & X. Zhao. (2017). Effect of zoledronic acid therapy on postmenopausal osteoporosis between the Uighur and Han population in Xinjiang: An open-label, long-term safety and efficacy study. Journal of Clinical Pharmacy and Therapeutics, 43, 336–341. https://doi.org/10.1111/jcpt.12647

Chicago

C. Xiang, Hong Yuan, Xu Wanlong, X. Xiao, Hong Wang, and X. Zhao. 2017. “Effect of Zoledronic Acid Therapy on Postmenopausal Osteoporosis between the Uighur and Han Population in Xinjiang: An Open-Label, Long-Term Safety and Efficacy Study.” Journal of Clinical Pharmacy and Therapeutics 43 (November): 336–41. doi:10.1111/jcpt.12647.